- Primary hyperparathyroidism in prostate cancer: guilty or not guilty?
G. Mazziotti et al, 2018, Endocrine CrossRef - Involvement of Par-4 in Breast Cancer
Simone Aparecida de Bessa-Garcia et al, 2021, Tumor Suppressor Par-4 CrossRef - Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC)
Paulo R de Alcantara Filho et al, 2018, Breast Cancer Management CrossRef - Par-4 in Chemoresistant Ovarian and Endometrial Cancers
François Fabi et al, 2021, Tumor Suppressor Par-4 CrossRef - Discovery and Overview of Par-4
Saptadwipa Ganguly et al, 2022, Tumor Suppressor Par-4 CrossRef - Role of Par-4 in B-Cell Hematological Malignancies
Sunil K. Noothi et al, 2021, Tumor Suppressor Par-4 CrossRef - Roles for Par-4 in Kidney Pathophysiology
Lu Ren et al, 2021, Tumor Suppressor Par-4 CrossRef - Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How
Sumanta K. Pal et al, 2020, European Urology CrossRef - Vitamin D Modulates PAR-4 Expression in an in Vitro Model of Osteoarthritis
Vanessa Mylenna Florêncio de Carvalho et al, 2022, Brazilian Archives of Biology and Technology CrossRef - Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang et al, 2020, Journal of Hematology & Oncology CrossRef - Identification and characterization of biomarkers and their functions for docetaxel‑resistant prostate cancer cells
Leihong Deng et al, 2019, Oncology Letters CrossRef - Abnormal Long Non-Coding RNAs Expression Patterns Have the Potential Ability for Predicting Survival and Treatment Response in Breast Cancer
Ana Carolina Pavanelli et al, 2021, Genes CrossRef